New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

As Pfizer acquires MET-097 maker Metsera, phase 2 data show potential for greater tolerability and once-monthly dosing.

Glucagon-like peptide-1 (GLP-1) medications have grown in popularity over the last few years. Common examples include semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound).

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

This is read by an automated voice. Please report any issues or inconsistencies here. If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to ...

As a 62-year-old grandmother in Maine, Christine Babb doesn’t identify with the biohacker bros who try experimental medications to optimize their health. But after side effects from her first dose of ...

Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Andy Cohen is admitting to dabbling in the world of weight loss drugs. The "Real Housewives" executive producer opened up about "micro-dosing" on an unnamed GLP-1 weight loss drug on his SiriusXM ...